Mepolizumab
Products in Health Canada’s databases that list Mepolizumab as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.
- Drug products
- 4
- 3 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 10
- Products in all
- 4
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| NUCALA (100 MG) | 02492989 | Marketed | Glaxosmithkline Inc | |
| NUCALA (100 MG) | 02492997 | Marketed | Glaxosmithkline Inc | |
| NUCALA (40 MG) | 02530821 | Marketed | Glaxosmithkline Inc | |
| NUCALA (100 MG) | 02449781 | Cancelled Post Market | Glaxosmithkline Inc |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- NUCALAJune 9, 2026 · NOC 37678
- NUCALANovember 28, 2023 · NOC 32218
- NUCALASeptember 15, 2022 · NOC 29007
- NUCALANovember 5, 2021 · NOC 26988
- NUCALASeptember 14, 2021 · NOC 26648
- NUCALAMarch 12, 2020 · NOC 23330
- NUCALANovember 21, 2019 · NOC 22918
- NUCALAOctober 8, 2019 · NOC 22758
- NUCALAJuly 17, 2018 · NOC 21089
- NUCALADecember 3, 2015 · NOC 17548